Genscript Biotech Corpora... (GNNSF)

PNK: GNNSF · Real-Time Price · USD

1.30

0.00 (0.00%)

At close: Apr 29, 2025, 8:00 PM

Genscript Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	2.86B	-350.98M	-431.69M	-496.38M	-281.9M	-113.69M	22.7M	38.52M	32.51M
Depreciation & Amortization	77.67M	74.05M	64.25M	47.78M	32.9M	20.64M	12.93M	7M	5.39M
Stock-Based Compensation	76.52M	60.59M	65.15M	39.69M	17.64M	10.78M	8.85M	2.81M	1.84M
Other Working Capital	4.56M	7.66M	120.2M	127.21M	62.98M	74.63M	263.91M	-19.03M	782K
Other Non-Cash Items	-3.03B	80.08M	-1.03M	138.41M	80.83M	-7.57M	-9.95M	-4.99M	-6.02M
Deferred Income Tax	n/a	n/a	13.27M	12.02M	15.93M	-8.23M	2.37M	-4.13M	-5.75M
Change in Working Capital	85.44M	-150.65M	169.75M	121.68M	-16.48M	68.11M	258.51M	-21.97M	-441K
Operating Cash Flow	75.65M	-286.91M	-120.29M	-136.79M	-151.09M	-29.95M	295.41M	21.37M	33.27M
Capital Expenditures	-147.92M	-157.71M	-203.57M	-137.4M	-127.75M	-118.54M	-79.61M	-31.97M	-8.98M
Cash Acquisitions	n/a	n/a	-914K	-3.76M	-2.07M	-9.81M	-29.48M	-1.03M	71K
Purchase of Investments	-3.36B	-5.74B	-409.62M	-322.56M	-430.73M	-1.33B	-75M	-4.22M	n/a
Sales Maturities Of Investments	2.57B	5.66B	187.69M	243.98M	462.99M	1.23B	830K	131K	n/a
Other Investing Acitivies	-512.4M	-115.89M	-16.88M	7.2M	-2.61M	19.88M	1.59M	-2.12M	167K
Investing Cash Flow	-1.46B	-357.73M	-443.3M	-212.55M	-100.17M	-208.63M	-181.67M	-36.45M	-8.31M
Debt Repayment	44.44M	49.78M	32.6M	-48.89M	24.2M	8.26M	10.5M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-9.46M	-7.77M	-11.47M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.63M	n/a
Other Financial Acitivies	8.59M	-11.69M	-36.59M	-194K	-10.55M	-3.26M	4.27M	1.74M	-2.79M
Financial Cash Flow	66.52M	1.07B	419.32M	902.14M	624.2M	-2.78M	257.27M	2.04M	8.49M
Net Cash Flow	-1.31B	422.4M	-156.97M	551.91M	376.66M	-242.16M	370.7M	-12.61M	32.74M
Free Cash Flow	-72.27M	-444.62M	-323.86M	-274.19M	-278.84M	-148.49M	215.8M	-10.6M	24.29M